Clinical Trials Browser

Phase 2 × Recurrence × Endostatins × Clear all

NCT04267978 2024-10-15

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Phase 2 Recruiting

Glioblastoma, Recurrence

NCT02636231 2021-02-03

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence